Tuesday, 6 Jan 2009 | Source: The Associated Press
Isis Pharmaceuticals Inc. said Tuesday it closed the $175 million sale of its remaining stake in Ibis Biosciences to Abbott Laboratories.
Posts |
COMPANY : ISIS Pharmaceuticals
1 Aug 2008
Posted By: Lightning Round OT
The Lightning Round is extended in this CNBC.com exclusive feature.... Read More
VIDEO | COMPANIES : ISIS Pharmaceuticals Inc
Discussing December chain store sales results, with Eric Beder, Brean Murray & Co., Inc. and Patti Freeman Evans, Forres...
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
The latest survey findings on Manhattan real estate, with Jonathan Miller, Miller Samuel, Inc. president/CEO
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC MOBILE | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2009 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes